These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3085628)

  • 1. Human monoamine oxidase. Lack of brain and platelet correlation.
    Young WF; Laws ER; Sharbrough FW; Weinshilboum RM
    Arch Gen Psychiatry; 1986 Jun; 43(6):604-9. PubMed ID: 3085628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
    Kettler R; Cesura AM; Dingemanse J; Da Prada M
    J Neural Transm Suppl; 1990; 32():211-4. PubMed ID: 2089093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro.
    Szutowicz A; Tomaszewicz M; Orsulak PJ
    J Biol Chem; 1989 Oct; 264(30):17660-4. PubMed ID: 2509446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M
    J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
    Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
    Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet monoamine oxidase type B by selegiline.
    Heinonen EH; Anttila MI; Nyman LM; Pyykkö KA; Vuorinen JA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):597-601. PubMed ID: 9243352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of human platelet monoamine oxidase.
    Fowler CJ; Wiberg A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):77-84. PubMed ID: 7207637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.
    Heinonen EH; Anttila MI; Karnani HL; Nyman LM; Vuorinen JA; Pyykkö KA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):602-9. PubMed ID: 9243353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for existence of A and B form monoamine oxidase in mitochondria from dog platelets.
    Obata T; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1987 Jun; 44(2):105-11. PubMed ID: 3116304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the absolute concentrations of monoamine oxidase A and B in human tissues.
    O'Carroll AM; Anderson MC; Tobbia I; Phillips JP; Tipton KF
    Biochem Pharmacol; 1989 Mar; 38(6):901-5. PubMed ID: 2495009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN; Harik SI
    J Neurochem; 1987 Nov; 49(5):1589-94. PubMed ID: 3117975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet and fibroblast monoamine oxidase in alcoholism.
    Giller E; Nocks J; Hall H; Stewart C; Schnitt J; Sherman B
    Psychiatry Res; 1984 Aug; 12(4):339-47. PubMed ID: 6594715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
    Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW
    Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of monoamine oxidase activities in synaptic and non-synaptic mitochondria derived from three brain regions: some functional implications.
    Lai JC; Leung TK; Lim L
    Metab Brain Dis; 1994 Mar; 9(1):53-66. PubMed ID: 8058030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose regimen of deprenyl (selegiline) and platelet MAO activities.
    Oreland L; Johansson F; Ekstedt J
    Acta Neurol Scand Suppl; 1983; 95():87-9. PubMed ID: 6428150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.